NCT01638832

Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 572 (estimated)
• Sponsor: Johann Wolfgang Goethe University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the association of non-alcoholic fatty liver disease and coronary artery disease. All patients presenting for coronary angiogram will receive the following examination: * Transient Elastography and Controlled Attenuation Parameter using the FibroScan * blood examination including biochemical markers The results of non-invasive liver steatosis and fibrosis measurement are compared with the results of coronary angiogram concerning the presence or absence of coronary artery disease.

Conditions

• Nonalcoholic Steatohepatitis (NASH)

Interventions

Type	Name	Description
DEVICE	Transient Elastography (FibroScan), Echosens, Paris, France
DEVICE	Controlled Attenuation Parameter (CAP), Echosens, Paris, France

Timeline

• Start date: 2012-06-01
• Primary completion: 2013-09-01
• Completion: 2013-12-01
• First posted: 2012-07-12
• Last updated: 2012-07-12

Locations

1 site across 1 country: Germany